Health & Safety

The Five Dumbest Product Bans

Eli Lehrer — Mon, 25 Feb 2008 23:00:00 -0800

This paper focuses on five clearly absurd product bans that seem to serve no social good.

Campaign Targets Unfair Political Assault on Bottled Water

Christine Hall — Mon, 20 Oct 2008 13:11:45 -0700

A new petition drive demands that politicians not continue plans to ban the product for safety workers and consumers. The campaign comes in the wake of a politically-motivated attack against bottled water, a study by an environmental pressure group designed to undermine confidence in the safety of the product.

the presidential candidates' views on the biotech industry

Richard Morrison — Mon, 6 Oct 2008 07:52:59 -0700

FDA approval for "biogeneric" drugs

Richard Morrison — Fri, 3 Oct 2008 14:16:58 -0700

Activists Hit the (Plastic) Bottle Again

Steven J. Milloy — Thu, 18 Sep 2008 12:54:45 -0700

Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.

CAFE Oh Nay, Standard Has Hurt

Sam Kazman — Wed, 17 Sep 2008 00:00:00 -0700

Cholesterol Drug Scare Shenanigans

Steven J. Milloy — Thu, 4 Sep 2008 13:00:17 -0700

Why is the editor of the New England Journal of Medicine encouraging a cancer scare over the cholesterol-lowering drug Vytorin? Is he overcompensating for past bad behavior?

Public Funding for Stem Cell Research: Boon or Boondoggle?

Christine Hall — Thu, 4 Sep 2008 10:51:00 -0700

Debates over the ethics of research using human embryonic stem cells continue long after the Bush Administration’s ban on federal tax-funding for such research. But, a new report from the Competitive Enterprise Institute calls into question whether, ethics aside, stem cell research is even a sensible expenditure of taxpayer dollars.

Public Stem Cell Research Funding

Sigrid Fry-Revere — Wed, 3 Sep 2008 00:00:00 -0700

The best way to make progress in stem cell research is to allow the private sector to grow, unimpeded by regulation and controversy.

Sick Patients Need Cutting-Edge Drugs

Gregory Conko — Sat, 23 Aug 2008 00:00:00 -0700

The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.